MDT

96.67

+0.59%↑

137.56

-0.2%↓

VEEV

224.65

-0.07%↓

HQY

91.97

-0.76%↓

PHR.US

+0.18%↑

MDT

96.67

+0.59%↑

137.56

-0.2%↓

VEEV

224.65

-0.07%↓

HQY

91.97

-0.76%↓

PHR.US

+0.18%↑

MDT

96.67

+0.59%↑

137.56

-0.2%↓

VEEV

224.65

-0.07%↓

HQY

91.97

-0.76%↓

PHR.US

+0.18%↑

MDT

96.67

+0.59%↑

137.56

-0.2%↓

VEEV

224.65

-0.07%↓

HQY

91.97

-0.76%↓

PHR.US

+0.18%↑

MDT

96.67

+0.59%↑

137.56

-0.2%↓

VEEV

224.65

-0.07%↓

HQY

91.97

-0.76%↓

PHR.US

+0.18%↑

Inicio・Lista de Acciones・Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings Inc

Cerrado

SectorSanidad

37.58 -0.71

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

37.14

Máximo

37.79

Métricas clave
By Trading Economics
Ingresos	11M 51M
Ventas	39M 239M
P/B Media del Sector	12.259 78.892
BPA	1.08
Margen de beneficios	21.242
Empleados	268
EBITDA	14M 73M

Recomendaciones
By TipRanks
Recomendaciones	Comprar
Estimación a 12 Meses	+14.35% upside

Estadísticas de Mercado
By TradingEconomics
Capitalización Mercado	551M 2.2B
Apertura anterior	38.29
Cierre anterior	37.58

Puntuación técnica

By Trading Central

Confianza

Weak Bullish Evidence

29.8 / N/A Soporte y Resistencia

Harmony Biosciences Holdings Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

30 dic 2025, 23:49 UTC

Adquisiciones, fusiones, absorciones

WiseTech to Sell Expedient to Appease Competition Regulator

30 dic 2025, 17:12 UTC

Principales Movimientos del Mercado

CapsoVision Shares Rise on FDA Application for AI Tool in Swallowable Camera

30 dic 2025, 21:50 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

30 dic 2025, 21:16 UTC

Adquisiciones, fusiones, absorciones

Penguin Solutions: Smart Modular to Sell Zilia Stake for $46M

30 dic 2025, 21:08 UTC

Charlas de Mercado

U.S. Natural Gas Futures Take Another Wild Ride -- Market Talk

30 dic 2025, 20:41 UTC

Charlas de Mercado

Oil Futures Settle Lower in Sluggish Trade -- Market Talk

30 dic 2025, 20:37 UTC

Ganancias

The 5 Best Names to Play AI in 2026, According to Wall Street's Loudest Tech Bull -- Barrons.com

30 dic 2025, 19:29 UTC

Charlas de Mercado

Corn Extends Pullback in Light Trade -- Market Talk

30 dic 2025, 18:29 UTC

Charlas de Mercado

U.S. Oil Rig Count Rises By Three to 412 -- Market Talk

30 dic 2025, 17:20 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

30 dic 2025, 16:20 UTC

Ganancias

Boeing Stock Is on a Roll. Why It Could Gain 25% in the Next Year. -- Barrons.com

30 dic 2025, 16:18 UTC

Adquisiciones, fusiones, absorciones

Meta Buys AI Startup Manus, Adding Millions of Paying Users -- 2nd Update

30 dic 2025, 16:10 UTC

Charlas de Mercado

Eurozone Government Bond Yields Rise, Euro Falls Ahead of Fed Minutes -- Market Talk

30 dic 2025, 15:24 UTC

Charlas de Mercado

Australian Dollar Could Rise Versus Sterling -- Market Talk

30 dic 2025, 15:10 UTC

Adquisiciones, fusiones, absorciones

Meta Stock Rises After Buying Manus. What the China-Founded AI Start-Up Brings. -- Barrons.com

30 dic 2025, 14:24 UTC

Adquisiciones, fusiones, absorciones

LVMH: The Three Publications Are Challenges, Sciences & Avenir, and La Recherche

30 dic 2025, 14:22 UTC

Adquisiciones, fusiones, absorciones

LVMH : Szafran Will Serve as Publishing Director For all Three Publications

30 dic 2025, 14:20 UTC

Adquisiciones, fusiones, absorciones

LVMH: As Part of the Deal, Maurice Szafran Has Been Named President of Les Editions Croque Futur

30 dic 2025, 14:17 UTC

Adquisiciones, fusiones, absorciones

LVMH: The Deal Also Reflects LVMH's Commitment to Support High-Quality Information and Scientific Culture

30 dic 2025, 14:16 UTC

Adquisiciones, fusiones, absorciones

LVMH: The Deal Aims to Accelerate the Development and Distribution of the Publications Mainly in Digital Format

30 dic 2025, 14:14 UTC

Adquisiciones, fusiones, absorciones

LVMH: The Move Includes Three Publications Into UFIPAR Investment Company

30 dic 2025, 14:12 UTC

Adquisiciones, fusiones, absorciones

LVMH: Les Editions Croque Futur Is a French Publishing House

30 dic 2025, 14:10 UTC

Adquisiciones, fusiones, absorciones

LVMH Acquires Les Editions Croque Futur

30 dic 2025, 13:49 UTC

Adquisiciones, fusiones, absorciones

Meta Buys Manus. What the China-Founded AI Start-Up Brings for Zuckerberg. -- Barrons.com

30 dic 2025, 13:36 UTC

Charlas de Mercado

U.S. Natural Gas Continues Weather-Driven Rally -- Market Talk

30 dic 2025, 13:30 UTC

Charlas de Mercado

Crude Futures Gain in Light Holiday Trade -- Market Talk

30 dic 2025, 12:55 UTC

Charlas de Mercado

Triple Flag Precious Metals Offers Opportunity While Mitigating Risk -- Market Talk

30 dic 2025, 11:55 UTC

Charlas de Mercado

Ganancias

Investors Await Tesco's Profit Outlook Following U.K. Budget Reforms -- Market Talk

30 dic 2025, 11:47 UTC

Ganancias

Adquisiciones, fusiones, absorciones

Meta's Manus Deal Is a Taster of AI Trends for 2026. Watch This Risk. -- Barrons.com

30 dic 2025, 11:35 UTC

Adquisiciones, fusiones, absorciones

Meta Buys Manus. What the China-Founded AI Start-Up Brings for Zuckerberg. -- Barrons.com

Comparación entre iguales

Cambio de precio

Harmony Biosciences Holdings Inc previsión

Precio Objetivo

By TipRanks

14.35% repunte

Estimación a 12 Meses

Media 43.6 USD 14.35%

Máximo 55 USD

Mínimo 32 USD

De acuerdo con 6 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Harmony Biosciences Holdings Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

6 ratings

Comprar

Mantener

Vender

De acuerdo con 6 analistas que ofrecen calificaciones bursátiles a para Harmony Biosciences Holdings Inc Dist en los últimos 3 meses.

Puntuación técnica

By Trading Central

29.8 / N/ASoporte y Resistencia

Bullish events outweigh bearish events.

Recent bullish events outweigh bearish events.

All events are bearish.

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States. The company offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. It also offers HBS-102, a melanin-concentrating hormone receptor 1 for MCH neurons. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is headquartered in Plymouth Meeting, Pennsylvania.